Squarepoint Ops LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$5,333,748
+275.0%
336,090
+345.9%
0.01%
+225.0%
Q2 2023$1,422,345
+17.9%
75,376
-69.0%
0.00%
-20.0%
Q4 2022$1,206,247
-27.9%
243,195
-30.5%
0.01%
-37.5%
Q3 2022$1,673,000
+219.9%
350,010
+201.1%
0.01%
+166.7%
Q2 2022$523,000
-57.2%
116,229
-54.8%
0.00%
-40.0%
Q1 2022$1,223,000
+169.4%
256,950
+319.8%
0.01%
+400.0%
Q4 2021$454,000
+18.5%
61,208
-9.4%
0.00%0.0%
Q3 2021$383,000
-51.0%
67,594
-42.9%
0.00%
-66.7%
Q2 2021$781,000
-64.8%
118,470
-56.7%
0.00%
-76.9%
Q1 2021$2,216,000
+61.9%
273,526
+28.9%
0.01%
+30.0%
Q4 2020$1,369,000
+293.4%
212,188
+119.2%
0.01%
+100.0%
Q3 2020$348,000
+120.3%
96,783
+182.1%
0.01%
+66.7%
Q2 2020$158,000
+8.2%
34,308
-20.1%
0.00%
-25.0%
Q1 2020$146,000
-90.0%
42,918
-85.0%
0.00%
-55.6%
Q4 2019$1,458,000
+0.1%
285,555
-52.6%
0.01%
-30.8%
Q3 2019$1,456,000
+1465.6%
601,826
+1306.4%
0.01%
+1200.0%
Q2 2019$93,000
-88.6%
42,791
-85.8%
0.00%
-88.9%
Q1 2019$819,000
-41.0%
302,181
+4.5%
0.01%
-43.8%
Q4 2018$1,387,000
+63.4%
289,056
+222.2%
0.02%
+60.0%
Q3 2018$849,000
-3.9%
89,700
-1.2%
0.01%
-16.7%
Q2 2018$883,000
+103.9%
90,800
+120.4%
0.01%
+71.4%
Q1 2018$433,000
+183.0%
41,200
-45.1%
0.01%
+16.7%
Q4 2016$153,000
-53.2%
75,083
+211.5%
0.01%
-83.3%
Q4 2015$327,00024,1000.04%
Other shareholders
IMMUNOGEN INC shareholders Q4 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders